Research supported by the JKTG Foundation has been published in the journal Science Translational Medicine.
The research, Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin, includes work by Andrew Ewald, PhD, with Johns Hopkins University School of Medicine, a researcher with whom JKTG has worked on several projects.
The work highlighted in this most recent publication investigates the molecular mechanisms that cause metastasis in triple-negative breast cancer.
Learn more about Dr. Ewald’s work, as well as research from other leading breast cancer researchers, at the Foundation’s Oct. 27 symposium Moving Breast Cancer Treatments Forward. Additional details and registration can be found on the event site.
Featured news
Ted’s Take: What is your role in health and health equity?
As we talk and plan for improvements in virtually anything, it’s important that we examine what our role in that process is and should be.
Ted’s Take: Medicare for all – HUH?
Around every national election, the phrase Medicare for All comes up. My reaction is simple: HUH? Here’s why?
JKTG-Funded Research Tackles Possible Way to Stop Spread of Breast Cancer
New JKTG Foundation-funded research identifies potential new immune system target to head off the spread of breast cancer cells. The work is from the Johns Hopkins Giovanis Institute and appears in the journal Oncogene.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133